As per our report, the global anatomic pathology market size is predicted to grow USD 26.1 billion by 2024 from USD 19.4 billion in 2019. The market is forecasted to grow at a CAGR of 6.16% during the forecast period.
Anatomic Pathology is a branch of pathology which can be defined as a specialization of medicine, in which the diagnosis of the disease is carried out by examining tissues and organs at a microscopic, biochemical, immunological, and macroscopic levels. The critical function of anatomy pathology is to detect abnormalities that can be helpful to enhance diagnostics and treatment management. Anatomy pathology is most frequently applied to identify different types of tumours and cancers, liver and kidney diseases, infections, and autoimmune disorders. The lines are blurring between the clinical pathology and anatomical pathology owing to the technological advancements leading to the overlapping of both the branches, the procedures like flow cytometry, molecular pathology, cytogenetics can be performed on both fluid samples and tissue samples.
In clinical centres, anatomic pathology is a technology used to diagnose the diseases with microscopic, macroscopic and other instruments. Modern technologies are playing a pivotal role in processing, examining and diagnosing of cancer diseases and are making the right decisions over treatment procedures.
MARKET DRIVERS
Rising the ageing population across the world and increasing incidences of chronic diseases due to changes in food habits and lifestyle are primarily accelerating the global anatomic pathology market. Growing demand to improve the diagnostic procedures in every clinical centre is further propelling the market.
Additionally, increasing concern towards health and also a priority for early diagnosis and rise in the disposable income in urban areas are lavishing the demand of the market to the extent. The adoption of the latest technologies and also the launch of innovative techniques in the medical sector is boosting the anatomic pathology market.
Further, the growing prevalence for the effective treatment procedures and also to promote the wellbeing of the patient after surgeries is creating chances for the anatomic pathology market to grow. Increasing investments on the construction of hospitals by the government are likely to bolster the demand of the anatomic pathology market.
MARKET RESTRAINTS
Lack of standardization is slowly hampering the demand of the market. Stringent rules and regulations by the government are also impacting negatively on the growth of the anatomic pathology market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 to 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 to 2024 |
|
Segments Covered |
By Product Type, End-User, Application and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
In this research report, the global anatomic pathology market has been segmented based on the product type, end-user, application and region.
Anatomic Pathology Market Analysis - By Product
Based on product type, Instruments type is leading with the highest shares of the market. Changes in lifestyles and food habits, rise in the incidences of various health disorders, growing expenditure on healthcare are majorly elevating the growth of the anatomic pathology market. In the medical sector, there is a growing need to improve the diagnostic procedures and also to analyze the issue with a clear vision to promote effective treatment for the patient is significantly influencing the demand of the market.
Anatomic Pathology Market Analysis - By End-User
Based on the end-user, the diagnostics lab segment is contributing the highest shares for the market. Increasing support from both private and public organizations in healthcare centres is accelerating the demand of the market. Growing awareness over the availability of various diagnostic procedures for many health disorders is likely to outshine the need of the market. The rise in the number of research institutes in the medical sector is lavishing the growth of the anatomic pathology market.
Anatomic Pathology Market Analysis - By Application
Lymphoma application is witnessed in holding prominent shares of the market with the adoption of the latest technology in diagnosing and treating the disease. Increasing disposable income, especially in urban areas, is also one of the factors fueling the growth of the market. The growing tendency to launch innovative devices in favour of the end-users is ascribed to bolster the demand of the market. Rise in the revenue in developed and developing countries is also to magnify the significant growth rate of the anatomic pathology market.
Regional Analysis
North America is accounted for holding the highest shares of the market. Rise in the awareness over the diagnosis procedures is driving the growth of the anatomic pathology industry. Besides, the growing number of research institutes to improve the performance is boosting up the demand of the market.
The Asia Pacific is following North America in holding the most significant shares of the market. The growing geriatric population is one of the factors outshining the demand of the business. Also, increasing the construction of hospitals with the latest equipment is broadening the growth of the anatomic pathology market.
Europe witnessed the fastest growth rate from the past few years, and it is deemed to have a significant growth rate in the coming years. Acceptance of the latest technologies and implementation of new devices at a high success rate is escalating the demand of the European market.
The Middle East and Africa are expected to have slight variations in the growth rate shortly.
TOP COMPANIES IN THE MARKET
Noteworthy companies in the global anatomic pathology market profiled in this report are F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis andBISWorld'sBISWorld's Pathology Services.
RECENT HAPPENINGS IN THE MARKET
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End-User
5.2.1 Introduction
5.2.2 Diagnostics Lab
5.2.3 Hospitals
5.2.4 Physicians' Office Lab
5.2.5 Y-o-Y Growth Analysis, By End-User
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By End-User
5.3 Application
5.3.1 Introduction
5.3.2 Lymphoma
5.3.3 Breast
5.3.4 Lung
5.3.5 Cervical
5.3.6 Colorectal
5.3.7 Prostate
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End-User
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End-User
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End-User
6.1.5.4 By Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 NeoGenomics Laboratories Inc.
8.3 Laboratory Corporation of America Holdings
8.4 Thermo Fisher Scientific
8.5 Quest Diagnostics Incorporated
8.6 Agilent Technologies
8.7 Danaher Corporation
8.8 Sakura Finetechnical Co. Ltd.
8.9 Metropolis
8.10 IBISWorld’s Pathology Services
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
